Heyman Irwin A 4
4 · Anacor Pharmaceuticals Inc · Filed Apr 4, 2011
Insider Transaction Report
Form 4
Heyman Irwin A
Senior VP Product Development
Transactions
- Award
Stock Option (right to buy)
2011-03-31+52,900→ 52,900 totalExercise: $6.92Exp: 2021-03-30→ Common Stock (52,900 underlying)
Footnotes (1)
- [F1]1/4 of the shares subject to the option shall vest and become exercisable on the 12 month anniversary of the Vesting Commencement Date and 1/48 of the shares subject to the option shall vest and become exercisable on each monthly anniversary thereafter. Vesting Commencement Date is January 1, 2011.